Smeenk J

No ORCID on file · 4 papers in corpus
2024
BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae092

Study questionHow does a gonadotrophin-releasing hormone (GnRH) agonist versus a GnRH antagonist protocol affect ovarian response when using an individualized fixed daily dose of follitropin delta for ovarian stimulation?Summary answerThe B…

2024
Survey on ART and IUI: legislation, regulation, funding, and registries in European countries-an update.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae163

Study questionHow are ART and IUI regulated, funded, and registered in European countries, and how has the situation changed since 2018?Summary answerOf the 43 countries performing ART and IUI in Europe, and participating in the survey, spe…

2022
Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial).
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab261

Study questionIs a single endometrial scratch prior to the second fresh IVF/ICSI treatment cost-effective compared to no scratch, when evaluated over a 12-month follow-up period?Summary answerThe incremental cost-effectiveness ratio (ICER) …

2021
Endometrial scratching in women with one failed IVF/ICSI cycle-outcomes of a randomised controlled trial (SCRaTCH).
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa268

Study questionDoes endometrial scratching in women with one failed IVF/ICSI treatment affect the chance of a live birth of the subsequent fresh IVF/ICSI cycle?Summary answerIn this study, 4.6% more live births were observed in the scratch g…